EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration

Jiemei Shi, Huan Xu, Hongmei Zhao, Jiajie Zhao, Lihui Chen, Ping Xu, Dan Jia, Chunhui Jiang

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.4.47 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Jiemei Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Vision Science, Eye and ENT Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Recombinant Fusion Proteins, Genetic Therapy, Receptors, Vascular Endothelial Growth Factor, Dependovirus. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Recombinant Fusion ProteinsGenetic TherapyReceptors, Vascular Endothelial Growth FactorDependovirusChoroidal NeovascularizationMacular DegenerationWet Macular DegenerationAnimalsMiceHumansGene Therapy AgentsDisease Models, AnimalVascular Endothelial Growth Factor AFemaleGenetic VectorsMaleTreatment OutcomeVisual AcuityMacaca fascicularis

Substanzen

Recombinant Fusion ProteinsafliberceptReceptors, Vascular Endothelial Growth FactorVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology and Vision Science, Eye and ENT Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Myopia and Related Eye Diseases, NHC, Shanghai, China.
  • Shanghai Correge Pharmaceutical Technology Co., Ltd., Shanghai, China.

Zitieren

APA

Shi, J., Xu, H., Zhao, H., Zhao, J., Chen, L., Xu, P., Jia, D., & Jiang, C. (2026). Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.4.47

Vancouver

Shi J, Xu H, Zhao H, Zhao J, Chen L, Xu P, et al. Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.4.47

BibTeX
@article{Shi2026,
  author = {Shi, Jiemei and Xu, Huan and Zhao, Hongmei and Zhao, Jiajie and Chen, Lihui and Xu, Ping and Jia, Dan and Jiang, Chunhui},
  title = {Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.4.47}
}
Kostenlos starten →